BioLineRx Ltd. (TLV:BLRX)
Israel · Delayed Price · Currency is ILS · Price in ILA 1.300
+0.100 (8.33%)
Apr 24, 2026, 11:25 AM IDT
BioLineRx Market Cap
BioLineRx has a market cap or net worth of 33.94 million as of April 24, 2026. Its market cap has decreased by -27.61% in one year.
Market Cap
33.94M
Enterprise Value
16.16M
Revenue
3.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.30
Market Cap Chart
Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 33.94M, an increase of 20,719.25%. That is a compound annual growth rate of 32.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 33.94M | -18.75% |
| Dec 31, 2025 | 41.77M | -51.17% |
| Dec 31, 2024 | 85.55M | -79.39% |
| Dec 31, 2023 | 415.08M | 314.57% |
| Dec 29, 2022 | 100.12M | -67.59% |
| Dec 30, 2021 | 308.95M | 60.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 456.74M |
| Geffen Residence & Renewal | 270.51M |
| Matricelf | 81.80M |
| Clal Biotechnology Industries | 52.70M |
| Evogene | 29.38M |
| BioLight Life Sciences | 24.18M |
| Can-Fite BioPharma | 20.77M |
| XTL Biopharmaceuticals | 18.92M |